Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation.
Islet transplantation (ITx) has potential as a therapy for patients with type 1 diabetes. For successful engraftment and insulin independence, the transplanted islets must establish an adequate, stable blood supply. Angiopoientin-1 (Ang1) is a specific growth factor that induces vascularization via the Tie2 or Tie1 receptor. In this study, we used an in vitro angiogenesis assay to evaluate islet function following transplantation and the effect of the Ang1 variant cartilage oligomeric matrix protein (COMP) Ang1 on isolated islets. The enhanced function of islets transduced with COMP-Ang1 was also confirmed in a streptozotocin (STZ)-induced diabetic mice model. In a three-dimensional collagen-based culture system, the transduction of COMP-Ang1 into islets significantly increased angiogenesis compared with the bacterial-β-galactosidase (LacZ)-transduced controls and an intact, nontransduced islet negative control group. COMP-Ang1 transduced islets also attenuated hyperglycemia in syngeneic diabetic C57BL/6 mice and enhanced glucose tolerance by areas under the curves of intraperitoneal glucose tolerance tests. These findings demonstrated the capacity of COMP-Ang1 to promote revascularization in cultured islets, which may contribute to successful transplantation in vivo.
Park
K S
KS
Department of Molecular Medicine, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Shim
E Y
EY
Choi
B K
BK
Moon
C
C
Kim
S H
SH
Kim
Y S
YS
Kwon
C H
CH
Joh
J W
JW
Koh
G Y
GY
Kim
S J
SJ
D042683:Angiopoietin-1 / Q000235:genetics / Q000627:therapeutic use*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D014644:Genetic Variation; D005951:Glucose Tolerance Test; D006801:Humans; D016381:Islets of Langerhans Transplantation / Q000502:physiology*; D051379:Mice; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012016:Reference Values
D042683:Angiopoietin-1; D001786:Blood Glucose; C515576:COMP-Ang1 fusion protein; D011993:Recombinant Fusion Proteins